S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL) Article Swipe
Anne Largeot
,
Vanessa Klapp
,
Elodie Viry
,
Susanne Gonder
,
Iria Fernandez Botana
,
Arnaud Blomme
,
Mohaned Benzarti
,
Sandrine Pierson
,
Chloé Duculty
,
Petra Marttila
,
Marina Wierz
,
Ernesto Gargiulo
,
Giulia Pagano
,
Ning An
,
Najla El Hachem
,
Daniel Pérez-Hernández
,
Supriya Chakraborty
,
Loïc Ysebaert
,
Jean-Hugues François
,
Susan Cortez
,
Guy Berchem
,
Dimitar G. Efremov
,
Gunnar Dittmar
,
Martyna Szpakowska
,
Andy Chevigné
,
Petr V. Nazarov
,
Thomas Helleday
,
Pierre Close
,
Johannes Meiser
,
Basile Stamatopoulos
,
Laurent Désaubry
,
Jérôme Paggetti
,
Etienne Moussay
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1097/01.hs9.0000967476.52627.ab
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1097/01.hs9.0000967476.52627.ab
Background: CLL is the most common type of leukemia in adult, and despite great advance in the standard of care in the last decades, there is still no cure available. CLL cells are dependent on their microenvironment for proliferation and survival. Microenvironmental stimuli are associated with an increase in translation globally but also at the level of specific transcripts, including the MYC oncogene. Interestingly, translation was recognized as one “Achilles’ heel” of cancer cells and increased translation seems to be a common feature of a large variety of tumors. Several inhibitors of translation are available. We used FL3, a synthetic flavagline that was shown to bind prohibitins (PHBs). These proteins are found in several cellular localizations that dictate their activity. At the membrane, they are required for the RAF activation by RAS in a large variety of cancers, leading to the phosphorylation of eukaryotic initiation factor 4E (eIF4E) through the MAPK pathway, and ultimately resulting in increased translation. By binding to PHBs, FL3 was shown to prevent the activation of RAF and therefore decreases the translation. Aims: Here, we tested the targeting of translation initiation in CLL as a novel therapeutic strategy and aimed to dissect the mechanism of action of FL3, a translation inhibitor. Methods: We used CLL cells from patients, human and murine cell lines. We performed O-propargyl-puromycin (OPP) and L-homopropargylglycine (HPG) incorporation assays; Proximity Ligation Assay (PLA) of the interaction between translation initiation factors eIF4E and eIF4G; pulsed SILAC and polysome profiling to assess translation rate. We carried-out metabolomics analysis using [U-13C]-glucose and [U-13C]-glutamine tracing. Co-immunoprecipitation, PLA, Nano-BRET and cap-pull down were used to validate protein interactions. In vivo validation were done by adoptive transfer of splenocytes from sick Eµ-TCL1 mice. Finally, we performed qPCR of 6 genes from the translation initiation machinery and of PHBs in a cohort of 144 patients to determine correlation between expression of these genes and clinical parameters. Results: We showed that CLL cells display a high translation rate (A), which can be inhibited by FL3 (B). A multiomics analysis consisting of pulsed SILAC, RNA sequencing and polysome profiling performed in CLL patient samples and cell lines treated with FL3 revealed the decreased translation of the MYC oncogene (C). Furthermore, inhibition of translation was associated with a block of proliferation (D) and a profound rewiring of MYC-driven metabolism. Interestingly, contrary to other models, in CLL, the RAS-RAF-(PHBs)-MAPK pathway is neither impaired by FL3 nor implicated in translation regulation. We rather showed that PHBs are directly associated with the translation initiation complex (E). Knock-down of PHBs resembled FL3 treatment (F), confirming the direct involvement of PHBs in translation initiation. Importantly, inhibition of translation was efficient in controlling CLL development in vivo (G). Finally, high expression of translation initiation-related genes and PHBs genes correlated with poor survival and unfavorable clinical parameters in CLL patients (H). Summary/Conclusion: We demonstrated that translation inhibition is a valuable strategy to control CLL development by blocking the translation of several oncogenic pathways including MYC. We also unraveled a new and direct role of PHBs in translation initiation, thus creating new therapeutic opportunities for CLL patients.Keywords: Chronic lymphocytic leukemia, Targeted therapy
Related Topics
Concepts
EIF4E
EIF4G
Translation (biology)
Eukaryotic translation
Biology
Cancer research
Cell biology
Biochemistry
Messenger RNA
Gene
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/01.hs9.0000967476.52627.ab
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4385667481
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4385667481Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/01.hs9.0000967476.52627.abDigital Object Identifier
- Title
-
S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-08-01Full publication date if available
- Authors
-
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Pérez-Hernández, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Cortez, Guy Berchem, Dimitar G. Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigné, Petr V. Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne MoussayList of authors in order
- Landing page
-
https://doi.org/10.1097/01.hs9.0000967476.52627.abPublisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1097/01.hs9.0000967476.52627.abDirect OA link when available
- Concepts
-
EIF4E, EIF4G, Translation (biology), Eukaryotic translation, Biology, Cancer research, Cell biology, Biochemistry, Messenger RNA, GeneTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4385667481 |
|---|---|
| doi | https://doi.org/10.1097/01.hs9.0000967476.52627.ab |
| ids.doi | https://doi.org/10.1097/01.hs9.0000967476.52627.ab |
| ids.openalex | https://openalex.org/W4385667481 |
| fwci | 0.0 |
| type | article |
| title | S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| biblio.issue | S3 |
| biblio.volume | 7 |
| biblio.last_page | e52627ab |
| biblio.first_page | e52627ab |
| topics[0].id | https://openalex.org/T11157 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9161999821662903 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2716 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Chronic Lymphocytic Leukemia Research |
| is_xpac | False |
| apc_list.value | 1200 |
| apc_list.currency | USD |
| apc_list.value_usd | 1200 |
| apc_paid.value | 1200 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1200 |
| concepts[0].id | https://openalex.org/C161295673 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9152836203575134 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5408696 |
| concepts[0].display_name | EIF4E |
| concepts[1].id | https://openalex.org/C2776054693 |
| concepts[1].level | 5 |
| concepts[1].score | 0.7855676412582397 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5323186 |
| concepts[1].display_name | EIF4G |
| concepts[2].id | https://openalex.org/C149364088 |
| concepts[2].level | 4 |
| concepts[2].score | 0.584463894367218 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q185917 |
| concepts[2].display_name | Translation (biology) |
| concepts[3].id | https://openalex.org/C4718897 |
| concepts[3].level | 5 |
| concepts[3].score | 0.5555174350738525 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q5408698 |
| concepts[3].display_name | Eukaryotic translation |
| concepts[4].id | https://openalex.org/C86803240 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5437818765640259 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[4].display_name | Biology |
| concepts[5].id | https://openalex.org/C502942594 |
| concepts[5].level | 1 |
| concepts[5].score | 0.48893752694129944 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[5].display_name | Cancer research |
| concepts[6].id | https://openalex.org/C95444343 |
| concepts[6].level | 1 |
| concepts[6].score | 0.44422757625579834 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[6].display_name | Cell biology |
| concepts[7].id | https://openalex.org/C55493867 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2245476245880127 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[7].display_name | Biochemistry |
| concepts[8].id | https://openalex.org/C105580179 |
| concepts[8].level | 3 |
| concepts[8].score | 0.1544753611087799 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q188928 |
| concepts[8].display_name | Messenger RNA |
| concepts[9].id | https://openalex.org/C104317684 |
| concepts[9].level | 2 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[9].display_name | Gene |
| keywords[0].id | https://openalex.org/keywords/eif4e |
| keywords[0].score | 0.9152836203575134 |
| keywords[0].display_name | EIF4E |
| keywords[1].id | https://openalex.org/keywords/eif4g |
| keywords[1].score | 0.7855676412582397 |
| keywords[1].display_name | EIF4G |
| keywords[2].id | https://openalex.org/keywords/translation |
| keywords[2].score | 0.584463894367218 |
| keywords[2].display_name | Translation (biology) |
| keywords[3].id | https://openalex.org/keywords/eukaryotic-translation |
| keywords[3].score | 0.5555174350738525 |
| keywords[3].display_name | Eukaryotic translation |
| keywords[4].id | https://openalex.org/keywords/biology |
| keywords[4].score | 0.5437818765640259 |
| keywords[4].display_name | Biology |
| keywords[5].id | https://openalex.org/keywords/cancer-research |
| keywords[5].score | 0.48893752694129944 |
| keywords[5].display_name | Cancer research |
| keywords[6].id | https://openalex.org/keywords/cell-biology |
| keywords[6].score | 0.44422757625579834 |
| keywords[6].display_name | Cell biology |
| keywords[7].id | https://openalex.org/keywords/biochemistry |
| keywords[7].score | 0.2245476245880127 |
| keywords[7].display_name | Biochemistry |
| keywords[8].id | https://openalex.org/keywords/messenger-rna |
| keywords[8].score | 0.1544753611087799 |
| keywords[8].display_name | Messenger RNA |
| language | en |
| locations[0].id | doi:10.1097/01.hs9.0000967476.52627.ab |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210211592 |
| locations[0].source.issn | 2572-9241 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2572-9241 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | HemaSphere |
| locations[0].source.host_organization | https://openalex.org/P4310318547 |
| locations[0].source.host_organization_name | Wolters Kluwer |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310318547 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | HemaSphere |
| locations[0].landing_page_url | https://doi.org/10.1097/01.hs9.0000967476.52627.ab |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:10428245 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | cc-by-nc-nd |
| locations[1].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10428245/pdf/hs9-7-e52627ab.pdf |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Hemasphere |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10428245 |
| locations[2].id | pmh:oai:doaj.org/article:cadb7e0ab439425bb2d02339f658e7b0 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | HemaSphere, Vol 7, p e52627ab (2023) |
| locations[2].landing_page_url | https://doaj.org/article/cadb7e0ab439425bb2d02339f658e7b0 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5062875146 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9388-8461 |
| authorships[0].author.display_name | Anne Largeot |
| authorships[0].countries | LU |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[0].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[0].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[0].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[0].institutions[0].country_code | LU |
| authorships[0].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Anne Largeot |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[1].author.id | https://openalex.org/A5090137595 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5507-1963 |
| authorships[1].author.display_name | Vanessa Klapp |
| authorships[1].countries | LU |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[1].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[1].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[1].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[1].institutions[0].country_code | LU |
| authorships[1].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Vanessa Klapp |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[2].author.id | https://openalex.org/A5087523722 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1226-1473 |
| authorships[2].author.display_name | Elodie Viry |
| authorships[2].countries | LU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[2].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[2].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[2].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[2].institutions[0].country_code | LU |
| authorships[2].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Elodie Viry |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[3].author.id | https://openalex.org/A5053897835 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7582-6905 |
| authorships[3].author.display_name | Susanne Gonder |
| authorships[3].countries | LU |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[3].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[3].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[3].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[3].institutions[0].country_code | LU |
| authorships[3].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Susanne Gonder |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[4].author.id | https://openalex.org/A5087726731 |
| authorships[4].author.orcid | https://orcid.org/0009-0009-6740-4222 |
| authorships[4].author.display_name | Iria Fernandez Botana |
| authorships[4].countries | LU |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[4].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[4].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[4].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[4].institutions[0].country_code | LU |
| authorships[4].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Iria Fernandez Botana |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[5].author.id | https://openalex.org/A5091705546 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4183-8726 |
| authorships[5].author.display_name | Arnaud Blomme |
| authorships[5].affiliations[0].raw_affiliation_string | GIGA Cancer, Liège, Belgium |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Arnaud Blomme |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | GIGA Cancer, Liège, Belgium |
| authorships[6].author.id | https://openalex.org/A5016758998 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6413-3983 |
| authorships[6].author.display_name | Mohaned Benzarti |
| authorships[6].countries | LU |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[6].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[6].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[6].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[6].institutions[0].country_code | LU |
| authorships[6].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mohaned Benzarti |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[7].author.id | https://openalex.org/A5065253019 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Sandrine Pierson |
| authorships[7].countries | LU |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[7].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[7].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[7].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[7].institutions[0].type | nonprofit |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[7].institutions[0].country_code | LU |
| authorships[7].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sandrine Pierson |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[8].author.id | https://openalex.org/A5045645648 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7643-0515 |
| authorships[8].author.display_name | Chloé Duculty |
| authorships[8].countries | LU |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[8].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[8].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[8].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[8].institutions[0].country_code | LU |
| authorships[8].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Chloé Duculty |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[9].author.id | https://openalex.org/A5069186037 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0115-8067 |
| authorships[9].author.display_name | Petra Marttila |
| authorships[9].countries | SE |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I28166907 |
| authorships[9].affiliations[0].raw_affiliation_string | Karolinska Institutet, Solna, Sweden |
| authorships[9].institutions[0].id | https://openalex.org/I28166907 |
| authorships[9].institutions[0].ror | https://ror.org/056d84691 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[9].institutions[0].country_code | SE |
| authorships[9].institutions[0].display_name | Karolinska Institutet |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Petra Marttila |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Karolinska Institutet, Solna, Sweden |
| authorships[10].author.id | https://openalex.org/A5085301295 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-4636-7671 |
| authorships[10].author.display_name | Marina Wierz |
| authorships[10].countries | LU |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[10].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[10].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[10].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[10].institutions[0].type | nonprofit |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[10].institutions[0].country_code | LU |
| authorships[10].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Marina Wierz |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[11].author.id | https://openalex.org/A5069026427 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-4485-4599 |
| authorships[11].author.display_name | Ernesto Gargiulo |
| authorships[11].countries | LU |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[11].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[11].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[11].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[11].institutions[0].type | nonprofit |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[11].institutions[0].country_code | LU |
| authorships[11].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ernesto Gargiulo |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[12].author.id | https://openalex.org/A5069394992 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2395-4731 |
| authorships[12].author.display_name | Giulia Pagano |
| authorships[12].countries | LU |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[12].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[12].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[12].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[12].institutions[0].type | nonprofit |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[12].institutions[0].country_code | LU |
| authorships[12].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Giulia Pagano |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[13].author.id | https://openalex.org/A5043567666 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-9512-6869 |
| authorships[13].author.display_name | Ning An |
| authorships[13].affiliations[0].raw_affiliation_string | GIGA Cancer, Liège, Belgium |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Ning An |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | GIGA Cancer, Liège, Belgium |
| authorships[14].author.id | https://openalex.org/A5086704311 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-4180-3016 |
| authorships[14].author.display_name | Najla El Hachem |
| authorships[14].affiliations[0].raw_affiliation_string | GIGA Cancer, Liège, Belgium |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Najla El Hachem |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | GIGA Cancer, Liège, Belgium |
| authorships[15].author.id | https://openalex.org/A5088454205 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-0266-9050 |
| authorships[15].author.display_name | Daniel Pérez-Hernández |
| authorships[15].countries | LU |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[15].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[15].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[15].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[15].institutions[0].type | nonprofit |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[15].institutions[0].country_code | LU |
| authorships[15].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Daniel Perez Hernandez |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[16].author.id | https://openalex.org/A5084923644 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-6517-0217 |
| authorships[16].author.display_name | Supriya Chakraborty |
| authorships[16].countries | IT |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I91080651 |
| authorships[16].affiliations[0].raw_affiliation_string | International Centre for Genetic Engineering and Biotechnology, Trieste, Italy |
| authorships[16].institutions[0].id | https://openalex.org/I91080651 |
| authorships[16].institutions[0].ror | https://ror.org/043bgf219 |
| authorships[16].institutions[0].type | nonprofit |
| authorships[16].institutions[0].lineage | https://openalex.org/I91080651 |
| authorships[16].institutions[0].country_code | IT |
| authorships[16].institutions[0].display_name | International Centre for Genetic Engineering and Biotechnology |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Supriya Chakraborty |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | International Centre for Genetic Engineering and Biotechnology, Trieste, Italy |
| authorships[17].author.id | https://openalex.org/A5013649293 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-4102-7261 |
| authorships[17].author.display_name | Loïc Ysebaert |
| authorships[17].countries | FR |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210098740 |
| authorships[17].affiliations[0].raw_affiliation_string | Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France |
| authorships[17].institutions[0].id | https://openalex.org/I4210098740 |
| authorships[17].institutions[0].ror | https://ror.org/014hxhm89 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210098740 |
| authorships[17].institutions[0].country_code | FR |
| authorships[17].institutions[0].display_name | Institut universitaire du cancer de Toulouse Oncopole |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Loic Ysebaert |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France |
| authorships[18].author.id | https://openalex.org/A5026990820 |
| authorships[18].author.orcid | https://orcid.org/0009-0006-3362-6431 |
| authorships[18].author.display_name | Jean-Hugues François |
| authorships[18].countries | LU |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I162487826 |
| authorships[18].affiliations[0].raw_affiliation_string | Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg |
| authorships[18].institutions[0].id | https://openalex.org/I162487826 |
| authorships[18].institutions[0].ror | https://ror.org/03xq7w797 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I162487826 |
| authorships[18].institutions[0].country_code | LU |
| authorships[18].institutions[0].display_name | Centre Hospitalier de Luxembourg |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Jean-Hugues François |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg |
| authorships[19].author.id | https://openalex.org/A5114073043 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Susan Cortez |
| authorships[19].countries | LU |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I162487826 |
| authorships[19].affiliations[0].raw_affiliation_string | Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg |
| authorships[19].institutions[0].id | https://openalex.org/I162487826 |
| authorships[19].institutions[0].ror | https://ror.org/03xq7w797 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I162487826 |
| authorships[19].institutions[0].country_code | LU |
| authorships[19].institutions[0].display_name | Centre Hospitalier de Luxembourg |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Susan Cortez |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg |
| authorships[20].author.id | https://openalex.org/A5042997291 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-0157-2257 |
| authorships[20].author.display_name | Guy Berchem |
| authorships[20].countries | LU |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I162487826 |
| authorships[20].affiliations[0].raw_affiliation_string | Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg |
| authorships[20].institutions[0].id | https://openalex.org/I162487826 |
| authorships[20].institutions[0].ror | https://ror.org/03xq7w797 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I162487826 |
| authorships[20].institutions[0].country_code | LU |
| authorships[20].institutions[0].display_name | Centre Hospitalier de Luxembourg |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Guy Berchem |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg |
| authorships[21].author.id | https://openalex.org/A5013747036 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-9081-5462 |
| authorships[21].author.display_name | Dimitar G. Efremov |
| authorships[21].countries | IT |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I91080651 |
| authorships[21].affiliations[0].raw_affiliation_string | International Centre for Genetic Engineering and Biotechnology, Trieste, Italy |
| authorships[21].institutions[0].id | https://openalex.org/I91080651 |
| authorships[21].institutions[0].ror | https://ror.org/043bgf219 |
| authorships[21].institutions[0].type | nonprofit |
| authorships[21].institutions[0].lineage | https://openalex.org/I91080651 |
| authorships[21].institutions[0].country_code | IT |
| authorships[21].institutions[0].display_name | International Centre for Genetic Engineering and Biotechnology |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Dimitar G Efremov |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | International Centre for Genetic Engineering and Biotechnology, Trieste, Italy |
| authorships[22].author.id | https://openalex.org/A5002715888 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-3647-8623 |
| authorships[22].author.display_name | Gunnar Dittmar |
| authorships[22].countries | LU |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[22].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[22].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[22].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[22].institutions[0].type | nonprofit |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[22].institutions[0].country_code | LU |
| authorships[22].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Gunnar Dittmar |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[23].author.id | https://openalex.org/A5052327708 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-5659-8377 |
| authorships[23].author.display_name | Martyna Szpakowska |
| authorships[23].countries | LU |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[23].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[23].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[23].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[23].institutions[0].type | nonprofit |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[23].institutions[0].country_code | LU |
| authorships[23].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Martyna Szpakowska |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[24].author.id | https://openalex.org/A5022850024 |
| authorships[24].author.orcid | https://orcid.org/0000-0003-4768-6743 |
| authorships[24].author.display_name | Andy Chevigné |
| authorships[24].countries | LU |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[24].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[24].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[24].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[24].institutions[0].type | nonprofit |
| authorships[24].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[24].institutions[0].country_code | LU |
| authorships[24].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Andy Chevigne |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Luxembourg Institue of Health, DII, Luxembourg, Luxembourg |
| authorships[25].author.id | https://openalex.org/A5013957833 |
| authorships[25].author.orcid | https://orcid.org/0000-0003-3443-0298 |
| authorships[25].author.display_name | Petr V. Nazarov |
| authorships[25].countries | LU |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[25].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[25].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[25].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[25].institutions[0].type | nonprofit |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[25].institutions[0].country_code | LU |
| authorships[25].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Petr V. Nazarov |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[26].author.id | https://openalex.org/A5029296072 |
| authorships[26].author.orcid | https://orcid.org/0000-0002-7384-092X |
| authorships[26].author.display_name | Thomas Helleday |
| authorships[26].countries | SE |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I28166907 |
| authorships[26].affiliations[0].raw_affiliation_string | Karolinska Institutet, Solna, Sweden |
| authorships[26].institutions[0].id | https://openalex.org/I28166907 |
| authorships[26].institutions[0].ror | https://ror.org/056d84691 |
| authorships[26].institutions[0].type | education |
| authorships[26].institutions[0].lineage | https://openalex.org/I28166907 |
| authorships[26].institutions[0].country_code | SE |
| authorships[26].institutions[0].display_name | Karolinska Institutet |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Thomas Helleday |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Karolinska Institutet, Solna, Sweden |
| authorships[27].author.id | https://openalex.org/A5030325551 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-8844-9616 |
| authorships[27].author.display_name | Pierre Close |
| authorships[27].affiliations[0].raw_affiliation_string | GIGA Cancer, Liège, Belgium |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Pierre Close |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | GIGA Cancer, Liège, Belgium |
| authorships[28].author.id | https://openalex.org/A5089914132 |
| authorships[28].author.orcid | https://orcid.org/0000-0002-9093-6210 |
| authorships[28].author.display_name | Johannes Meiser |
| authorships[28].countries | LU |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[28].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[28].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[28].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[28].institutions[0].type | nonprofit |
| authorships[28].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[28].institutions[0].country_code | LU |
| authorships[28].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Johannes Meiser |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[29].author.id | https://openalex.org/A5038527413 |
| authorships[29].author.orcid | https://orcid.org/0000-0002-0580-7394 |
| authorships[29].author.display_name | Basile Stamatopoulos |
| authorships[29].countries | BE |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I2801838318 |
| authorships[29].affiliations[0].raw_affiliation_string | ULB-Research Cancer Center (U-CRC), Jules Bordet Institute, Brussels, Belgium |
| authorships[29].institutions[0].id | https://openalex.org/I2801838318 |
| authorships[29].institutions[0].ror | https://ror.org/05e8s8534 |
| authorships[29].institutions[0].type | healthcare |
| authorships[29].institutions[0].lineage | https://openalex.org/I2801838318 |
| authorships[29].institutions[0].country_code | BE |
| authorships[29].institutions[0].display_name | Institut Jules Bordet |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Basile Stamatopoulos |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | ULB-Research Cancer Center (U-CRC), Jules Bordet Institute, Brussels, Belgium |
| authorships[30].author.id | https://openalex.org/A5071118882 |
| authorships[30].author.orcid | https://orcid.org/0000-0002-1192-2970 |
| authorships[30].author.display_name | Laurent Désaubry |
| authorships[30].countries | FR |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I68947357 |
| authorships[30].affiliations[0].raw_affiliation_string | INSERM-University of Strasbourg, Strasbourg, France |
| authorships[30].institutions[0].id | https://openalex.org/I154526488 |
| authorships[30].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[30].institutions[0].type | government |
| authorships[30].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[30].institutions[0].country_code | FR |
| authorships[30].institutions[0].display_name | Inserm |
| authorships[30].institutions[1].id | https://openalex.org/I68947357 |
| authorships[30].institutions[1].ror | https://ror.org/00pg6eq24 |
| authorships[30].institutions[1].type | education |
| authorships[30].institutions[1].lineage | https://openalex.org/I68947357 |
| authorships[30].institutions[1].country_code | FR |
| authorships[30].institutions[1].display_name | Université de Strasbourg |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Laurent Désaubry |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | INSERM-University of Strasbourg, Strasbourg, France |
| authorships[31].author.id | https://openalex.org/A5016115748 |
| authorships[31].author.orcid | https://orcid.org/0000-0001-9460-5876 |
| authorships[31].author.display_name | Jérôme Paggetti |
| authorships[31].countries | LU |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[31].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[31].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[31].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[31].institutions[0].type | nonprofit |
| authorships[31].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[31].institutions[0].country_code | LU |
| authorships[31].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Jérôme Paggetti |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[32].author.id | https://openalex.org/A5040774725 |
| authorships[32].author.orcid | https://orcid.org/0000-0002-0879-8067 |
| authorships[32].author.display_name | Etienne Moussay |
| authorships[32].countries | LU |
| authorships[32].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[32].affiliations[0].raw_affiliation_string | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| authorships[32].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[32].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[32].institutions[0].type | nonprofit |
| authorships[32].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[32].institutions[0].country_code | LU |
| authorships[32].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[32].author_position | last |
| authorships[32].raw_author_name | Etienne Moussay |
| authorships[32].is_corresponding | False |
| authorships[32].raw_affiliation_strings | Luxembourg Institue of Health, DoCR, Luxembourg, Luxembourg |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1097/01.hs9.0000967476.52627.ab |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11157 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9161999821662903 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2716 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Chronic Lymphocytic Leukemia Research |
| related_works | https://openalex.org/W1994713811, https://openalex.org/W2191160049, https://openalex.org/W2995196861, https://openalex.org/W3198954077, https://openalex.org/W2593792882, https://openalex.org/W2115804977, https://openalex.org/W2998881076, https://openalex.org/W2592237743, https://openalex.org/W2808978665, https://openalex.org/W2033425667 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1097/01.hs9.0000967476.52627.ab |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210211592 |
| best_oa_location.source.issn | 2572-9241 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2572-9241 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | HemaSphere |
| best_oa_location.source.host_organization | https://openalex.org/P4310318547 |
| best_oa_location.source.host_organization_name | Wolters Kluwer |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | HemaSphere |
| best_oa_location.landing_page_url | https://doi.org/10.1097/01.hs9.0000967476.52627.ab |
| primary_location.id | doi:10.1097/01.hs9.0000967476.52627.ab |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210211592 |
| primary_location.source.issn | 2572-9241 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2572-9241 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | HemaSphere |
| primary_location.source.host_organization | https://openalex.org/P4310318547 |
| primary_location.source.host_organization_name | Wolters Kluwer |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | HemaSphere |
| primary_location.landing_page_url | https://doi.org/10.1097/01.hs9.0000967476.52627.ab |
| publication_date | 2023-08-01 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.6 | 289 |
| abstract_inverted_index.A | 335 |
| abstract_inverted_index.a | 80, 84, 98, 133, 188, 202, 300, 323, 374, 380, 478, 498 |
| abstract_inverted_index.4E | 146 |
| abstract_inverted_index.At | 120 |
| abstract_inverted_index.By | 158 |
| abstract_inverted_index.In | 270 |
| abstract_inverted_index.We | 95, 206, 217, 249, 317, 406, 472, 495 |
| abstract_inverted_index.an | 46 |
| abstract_inverted_index.as | 67, 187 |
| abstract_inverted_index.at | 53 |
| abstract_inverted_index.be | 79, 330 |
| abstract_inverted_index.by | 130, 275, 332, 399, 485 |
| abstract_inverted_index.in | 9, 15, 20, 48, 112, 132, 155, 185, 299, 348, 391, 403, 433, 442, 446, 467, 505 |
| abstract_inverted_index.is | 2, 25, 396, 477 |
| abstract_inverted_index.no | 27 |
| abstract_inverted_index.of | 7, 18, 56, 71, 83, 87, 91, 136, 142, 169, 182, 198, 200, 230, 278, 288, 297, 302, 310, 339, 362, 369, 376, 383, 421, 431, 438, 452, 489, 503 |
| abstract_inverted_index.on | 34 |
| abstract_inverted_index.to | 78, 104, 139, 160, 165, 194, 245, 266, 305, 388, 481 |
| abstract_inverted_index.we | 178, 285 |
| abstract_inverted_index.(D) | 378 |
| abstract_inverted_index.144 | 303 |
| abstract_inverted_index.CLL | 1, 30, 186, 208, 320, 349, 444, 468, 483, 514 |
| abstract_inverted_index.FL3 | 162, 333, 357, 400, 424 |
| abstract_inverted_index.MYC | 61, 364 |
| abstract_inverted_index.RAF | 128, 170 |
| abstract_inverted_index.RAS | 131 |
| abstract_inverted_index.RNA | 342 |
| abstract_inverted_index.and | 11, 39, 74, 152, 171, 192, 213, 221, 238, 242, 255, 261, 296, 313, 344, 352, 379, 456, 463, 500 |
| abstract_inverted_index.are | 32, 43, 93, 110, 124, 411 |
| abstract_inverted_index.but | 51 |
| abstract_inverted_index.can | 329 |
| abstract_inverted_index.for | 37, 126, 513 |
| abstract_inverted_index.new | 499, 510 |
| abstract_inverted_index.nor | 401 |
| abstract_inverted_index.one | 68 |
| abstract_inverted_index.the | 3, 16, 21, 54, 60, 121, 127, 140, 149, 167, 174, 180, 196, 231, 292, 359, 363, 393, 415, 428, 487 |
| abstract_inverted_index.was | 65, 102, 163, 371, 440 |
| abstract_inverted_index.(A), | 327 |
| abstract_inverted_index.(B). | 334 |
| abstract_inverted_index.(C). | 366 |
| abstract_inverted_index.(E). | 419 |
| abstract_inverted_index.(F), | 426 |
| abstract_inverted_index.(G). | 448 |
| abstract_inverted_index.(H). | 470 |
| abstract_inverted_index.CLL, | 392 |
| abstract_inverted_index.FL3, | 97, 201 |
| abstract_inverted_index.MAPK | 150 |
| abstract_inverted_index.MYC. | 494 |
| abstract_inverted_index.PHBs | 298, 410, 422, 432, 457, 504 |
| abstract_inverted_index.PLA, | 259 |
| abstract_inverted_index.also | 52, 496 |
| abstract_inverted_index.bind | 105 |
| abstract_inverted_index.care | 19 |
| abstract_inverted_index.cell | 215, 353 |
| abstract_inverted_index.cure | 28 |
| abstract_inverted_index.done | 274 |
| abstract_inverted_index.down | 263 |
| abstract_inverted_index.from | 210, 280, 291 |
| abstract_inverted_index.high | 324, 450 |
| abstract_inverted_index.last | 22 |
| abstract_inverted_index.most | 4 |
| abstract_inverted_index.poor | 461 |
| abstract_inverted_index.qPCR | 287 |
| abstract_inverted_index.rate | 326 |
| abstract_inverted_index.role | 502 |
| abstract_inverted_index.sick | 281 |
| abstract_inverted_index.that | 101, 116, 319, 409, 474 |
| abstract_inverted_index.they | 123 |
| abstract_inverted_index.thus | 508 |
| abstract_inverted_index.type | 6 |
| abstract_inverted_index.used | 96, 207, 265 |
| abstract_inverted_index.vivo | 271, 447 |
| abstract_inverted_index.were | 264, 273 |
| abstract_inverted_index.with | 45, 356, 373, 414, 460 |
| abstract_inverted_index.(HPG) | 223 |
| abstract_inverted_index.(OPP) | 220 |
| abstract_inverted_index.(PLA) | 229 |
| abstract_inverted_index.Aims: | 176 |
| abstract_inverted_index.Assay | 228 |
| abstract_inverted_index.Here, | 177 |
| abstract_inverted_index.PHBs, | 161 |
| abstract_inverted_index.SILAC | 241 |
| abstract_inverted_index.These | 108 |
| abstract_inverted_index.aimed | 193 |
| abstract_inverted_index.block | 375 |
| abstract_inverted_index.cells | 31, 73, 209, 321 |
| abstract_inverted_index.eIF4E | 237 |
| abstract_inverted_index.found | 111 |
| abstract_inverted_index.genes | 290, 312, 455, 458 |
| abstract_inverted_index.great | 13 |
| abstract_inverted_index.human | 212 |
| abstract_inverted_index.large | 85, 134 |
| abstract_inverted_index.level | 55 |
| abstract_inverted_index.lines | 354 |
| abstract_inverted_index.mice. | 283 |
| abstract_inverted_index.novel | 189 |
| abstract_inverted_index.other | 389 |
| abstract_inverted_index.rate. | 248 |
| abstract_inverted_index.seems | 77 |
| abstract_inverted_index.shown | 103, 164 |
| abstract_inverted_index.still | 26 |
| abstract_inverted_index.their | 35, 118 |
| abstract_inverted_index.there | 24 |
| abstract_inverted_index.these | 311 |
| abstract_inverted_index.using | 253 |
| abstract_inverted_index.which | 328 |
| abstract_inverted_index.SILAC, | 341 |
| abstract_inverted_index.action | 199 |
| abstract_inverted_index.adult, | 10 |
| abstract_inverted_index.assess | 246 |
| abstract_inverted_index.cancer | 72 |
| abstract_inverted_index.cohort | 301 |
| abstract_inverted_index.common | 5, 81 |
| abstract_inverted_index.direct | 429, 501 |
| abstract_inverted_index.eIF4G; | 239 |
| abstract_inverted_index.factor | 145 |
| abstract_inverted_index.lines. | 216 |
| abstract_inverted_index.murine | 214 |
| abstract_inverted_index.pulsed | 240, 340 |
| abstract_inverted_index.rather | 407 |
| abstract_inverted_index.showed | 318, 408 |
| abstract_inverted_index.tested | 179 |
| abstract_inverted_index.(PHBs). | 107 |
| abstract_inverted_index.(eIF4E) | 147 |
| abstract_inverted_index.Chronic | 516 |
| abstract_inverted_index.Several | 89 |
| abstract_inverted_index.advance | 14 |
| abstract_inverted_index.assays; | 225 |
| abstract_inverted_index.between | 233, 308 |
| abstract_inverted_index.binding | 159 |
| abstract_inverted_index.complex | 418 |
| abstract_inverted_index.control | 482 |
| abstract_inverted_index.despite | 12 |
| abstract_inverted_index.dictate | 117 |
| abstract_inverted_index.display | 322 |
| abstract_inverted_index.dissect | 195 |
| abstract_inverted_index.factors | 236 |
| abstract_inverted_index.feature | 82 |
| abstract_inverted_index.heel” | 70 |
| abstract_inverted_index.leading | 138 |
| abstract_inverted_index.models, | 390 |
| abstract_inverted_index.neither | 397 |
| abstract_inverted_index.pathway | 395 |
| abstract_inverted_index.patient | 350 |
| abstract_inverted_index.prevent | 166 |
| abstract_inverted_index.protein | 268 |
| abstract_inverted_index.samples | 351 |
| abstract_inverted_index.several | 113, 490 |
| abstract_inverted_index.stimuli | 42 |
| abstract_inverted_index.therapy | 520 |
| abstract_inverted_index.through | 148 |
| abstract_inverted_index.treated | 355 |
| abstract_inverted_index.tumors. | 88 |
| abstract_inverted_index.variety | 86, 135 |
| abstract_inverted_index.Eµ-TCL1 | 282 |
| abstract_inverted_index.Finally, | 284, 449 |
| abstract_inverted_index.Ligation | 227 |
| abstract_inverted_index.Methods: | 205 |
| abstract_inverted_index.Results: | 316 |
| abstract_inverted_index.Targeted | 519 |
| abstract_inverted_index.adoptive | 276 |
| abstract_inverted_index.analysis | 252, 337 |
| abstract_inverted_index.blocking | 486 |
| abstract_inverted_index.cancers, | 137 |
| abstract_inverted_index.cap-pull | 262 |
| abstract_inverted_index.cellular | 114 |
| abstract_inverted_index.clinical | 314, 465 |
| abstract_inverted_index.contrary | 387 |
| abstract_inverted_index.creating | 509 |
| abstract_inverted_index.decades, | 23 |
| abstract_inverted_index.directly | 412 |
| abstract_inverted_index.globally | 50 |
| abstract_inverted_index.impaired | 398 |
| abstract_inverted_index.increase | 47 |
| abstract_inverted_index.leukemia | 8 |
| abstract_inverted_index.oncogene | 365 |
| abstract_inverted_index.pathway, | 151 |
| abstract_inverted_index.pathways | 492 |
| abstract_inverted_index.patients | 304, 469 |
| abstract_inverted_index.polysome | 243, 345 |
| abstract_inverted_index.profound | 381 |
| abstract_inverted_index.proteins | 109 |
| abstract_inverted_index.required | 125 |
| abstract_inverted_index.revealed | 358 |
| abstract_inverted_index.rewiring | 382 |
| abstract_inverted_index.specific | 57 |
| abstract_inverted_index.standard | 17 |
| abstract_inverted_index.strategy | 191, 480 |
| abstract_inverted_index.survival | 462 |
| abstract_inverted_index.tracing. | 257 |
| abstract_inverted_index.transfer | 277 |
| abstract_inverted_index.validate | 267 |
| abstract_inverted_index.valuable | 479 |
| abstract_inverted_index.Nano-BRET | 260 |
| abstract_inverted_index.Proximity | 226 |
| abstract_inverted_index.activity. | 119 |
| abstract_inverted_index.decreased | 360 |
| abstract_inverted_index.decreases | 173 |
| abstract_inverted_index.dependent | 33 |
| abstract_inverted_index.determine | 306 |
| abstract_inverted_index.efficient | 441 |
| abstract_inverted_index.including | 59, 493 |
| abstract_inverted_index.increased | 75, 156 |
| abstract_inverted_index.inhibited | 331 |
| abstract_inverted_index.leukemia, | 518 |
| abstract_inverted_index.machinery | 295 |
| abstract_inverted_index.mechanism | 197 |
| abstract_inverted_index.membrane, | 122 |
| abstract_inverted_index.oncogene. | 62 |
| abstract_inverted_index.oncogenic | 491 |
| abstract_inverted_index.patients, | 211 |
| abstract_inverted_index.performed | 218, 286, 347 |
| abstract_inverted_index.profiling | 244, 346 |
| abstract_inverted_index.resembled | 423 |
| abstract_inverted_index.resulting | 154 |
| abstract_inverted_index.survival. | 40 |
| abstract_inverted_index.synthetic | 99 |
| abstract_inverted_index.targeting | 181 |
| abstract_inverted_index.therefore | 172 |
| abstract_inverted_index.treatment | 425 |
| abstract_inverted_index.unraveled | 497 |
| abstract_inverted_index.Knock-down | 420 |
| abstract_inverted_index.MYC-driven | 384 |
| abstract_inverted_index.activation | 129, 168 |
| abstract_inverted_index.associated | 44, 372, 413 |
| abstract_inverted_index.available. | 29, 94 |
| abstract_inverted_index.confirming | 427 |
| abstract_inverted_index.consisting | 338 |
| abstract_inverted_index.correlated | 459 |
| abstract_inverted_index.eukaryotic | 143 |
| abstract_inverted_index.expression | 309, 451 |
| abstract_inverted_index.flavagline | 100 |
| abstract_inverted_index.implicated | 402 |
| abstract_inverted_index.inhibition | 368, 437, 476 |
| abstract_inverted_index.inhibitor. | 204 |
| abstract_inverted_index.inhibitors | 90 |
| abstract_inverted_index.initiation | 144, 184, 235, 294, 417 |
| abstract_inverted_index.multiomics | 336 |
| abstract_inverted_index.parameters | 466 |
| abstract_inverted_index.recognized | 66 |
| abstract_inverted_index.sequencing | 343 |
| abstract_inverted_index.ultimately | 153 |
| abstract_inverted_index.validation | 272 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.carried-out | 250 |
| abstract_inverted_index.controlling | 443 |
| abstract_inverted_index.correlation | 307 |
| abstract_inverted_index.development | 445, 484 |
| abstract_inverted_index.initiation, | 507 |
| abstract_inverted_index.initiation. | 435 |
| abstract_inverted_index.interaction | 232 |
| abstract_inverted_index.involvement | 430 |
| abstract_inverted_index.lymphocytic | 517 |
| abstract_inverted_index.metabolism. | 385 |
| abstract_inverted_index.parameters. | 315 |
| abstract_inverted_index.prohibitins | 106 |
| abstract_inverted_index.regulation. | 405 |
| abstract_inverted_index.splenocytes | 279 |
| abstract_inverted_index.therapeutic | 190, 511 |
| abstract_inverted_index.translation | 49, 64, 76, 92, 183, 203, 234, 247, 293, 325, 361, 370, 404, 416, 434, 439, 453, 475, 488, 506 |
| abstract_inverted_index.unfavorable | 464 |
| abstract_inverted_index.Furthermore, | 367 |
| abstract_inverted_index.Importantly, | 436 |
| abstract_inverted_index.demonstrated | 473 |
| abstract_inverted_index.metabolomics | 251 |
| abstract_inverted_index.transcripts, | 58 |
| abstract_inverted_index.translation. | 157, 175 |
| abstract_inverted_index.incorporation | 224 |
| abstract_inverted_index.interactions. | 269 |
| abstract_inverted_index.localizations | 115 |
| abstract_inverted_index.opportunities | 512 |
| abstract_inverted_index.proliferation | 38, 377 |
| abstract_inverted_index.Interestingly, | 63, 386 |
| abstract_inverted_index.“Achilles’ | 69 |
| abstract_inverted_index.[U-13C]-glucose | 254 |
| abstract_inverted_index.phosphorylation | 141 |
| abstract_inverted_index.microenvironment | 36 |
| abstract_inverted_index.[U-13C]-glutamine | 256 |
| abstract_inverted_index.Microenvironmental | 41 |
| abstract_inverted_index.initiation-related | 454 |
| abstract_inverted_index.patients.Keywords: | 515 |
| abstract_inverted_index.RAS-RAF-(PHBs)-MAPK | 394 |
| abstract_inverted_index.Summary/Conclusion: | 471 |
| abstract_inverted_index.O-propargyl-puromycin | 219 |
| abstract_inverted_index.L-homopropargylglycine | 222 |
| abstract_inverted_index.Co-immunoprecipitation, | 258 |
| cited_by_percentile_year | |
| countries_distinct_count | 5 |
| institutions_distinct_count | 33 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.699999988079071 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.34501098 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |